AggreDYNE

Houston, United States Founded: 2011 • Age: 15 yrs
Platelet stickiness is measured using patented Aggreguide A-100.
Request Access

About AggreDYNE

AggreDYNE is a company based in Houston (United States) founded in 2011.. AggreDYNE has raised $3 million across 1 funding round. AggreDYNE offers products and services including AggreGuide A-100. AggreDYNE operates in a competitive market with competitors including Accumetrics, COC Pharmaceuticals Industry, Zabit Pharmaceutical, ThrombusCheck and DCM Pharmaceutical Industry, among others.

  • Headquarter Houston, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Agoradyne, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3 M (USD)

    in 1 rounds

  • Latest Funding Round
    $3 M (USD), Series A

    Apr 23, 2012

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of AggreDYNE

AggreDYNE offers a comprehensive portfolio of products and services, including AggreGuide A-100. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

System for assessing platelet function using light scattering technology.

Funding Insights of AggreDYNE

AggreDYNE has successfully raised a total of $3M through 1 strategic funding round. The most recent funding activity was a Series A round of $3 million completed in April 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $3.0M
  • First Round

    (23 Apr 2012)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2012 Amount Series A - AggreDYNE Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by AggreDYNE

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - AggreDYNE

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aggredyne Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of AggreDYNE

AggreDYNE operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accumetrics, COC Pharmaceuticals Industry, Zabit Pharmaceutical, ThrombusCheck and DCM Pharmaceutical Industry, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Platelet function assays and coagulation systems are developed and marketed.
domain founded_year HQ Location
Develops diagnostic devices for platelet function analysis.
domain founded_year HQ Location
Develops innovative devices for platelet functioning tests.
domain founded_year HQ Location
Offers a device that mimics plaqued arteries for personalized anti-platelet therapy.
domain founded_year HQ Location
Creates innovative diagnostic devices for measuring platelet dysfunction in healthcare.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Aggredyne

Frequently Asked Questions about AggreDYNE

When was AggreDYNE founded?

AggreDYNE was founded in 2011 and raised its 1st funding round 1 year after it was founded.

Where is AggreDYNE located?

AggreDYNE is headquartered in Houston, United States. It is registered at Houston, Texas, United States.

Is AggreDYNE a funded company?

AggreDYNE is a funded company, having raised a total of $3M across 1 funding round to date. The company's 1st funding round was a Series A of $3M, raised on Apr 23, 2012.

What does AggreDYNE do?

AggreDYNE was founded in 2011 and is headquartered in Houston, United States. Operations center on platelet function monitoring in the medical diagnostics sector. The patented Aggreguide A-100 device is employed to assess blood platelet stickiness and evaluate responses to anti-platelet therapies, such as aspirin and ADP inhibitors. Distribution occurs through 16 partners spanning 38 countries.

Who are the top competitors of AggreDYNE?

AggreDYNE's top competitors include Accumetrics, COC Pharmaceuticals Industry and Zabit Pharmaceutical.

What products or services does AggreDYNE offer?

AggreDYNE offers AggreGuide A-100.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available